A systems biological approach suggests that transcriptional feedback regulation by dual‐specificity phosphatase 6 shapes extracellular signal‐related kinase activity in RAS‐transformed fibroblasts

No abstract is available for this paper.

• Publication year

  2009

• Venue

  The FEBS Journal

• Publication date

  2009-02-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1111/j.1742-4658.2008.06846.xPMID 19154344
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• p204 Protein Is a Novel Modulator of Ras Activity*

  2008cited by this paper
• Recurrent design patterns in the feedback regulation of the mammalian signalling network

  2008cited by this paper
• Dual-specificity MAP kinase phosphatases (MKPs) and cancer

  2008cited by this paper
• FGF induces oscillations of Hes1 expression and Ras/ERK activation.

  2008cited by this paper
• Systems analysis of MAPK signal transduction.

  2008cited by this paper
• Negative-feedback regulation of FGF signalling by DUSP6/MKP-3 is driven by ERK1/2 and mediated by Ets factor binding to a conserved site within the DUSP6/MKP-3 gene promoter

  2008cited by this paper
• Dusp6 (Mkp3) is a negative feedback regulator of FGF-stimulated ERK signaling during mouse development

  2007cited by this paper
• Growth factor-induced MAPK network topology shapes Erk response determining PC-12 cell fate

  2007cited by this paper
• Competing docking interactions can bring about bistability in the MAPK cascade.

  2007cited by this paper
• SRF is a nuclear repressor of Smad3-mediated TGF-beta signaling.

  2007cited by this paper
• A five-gene signature and clinical outcome in non-small-cell lung cancer.

  2007cited by this paper
• SRF is a nuclear repressor of Smad3-mediated TGF-β signaling

  2007cited by this paper
• Differential regulation of MAP kinase signalling by dual-specificity protein phosphatases

  2007cited by this paper
• Global Effects of Ras Signaling on the Genetic Program in Mammalian Cells

  2006cited by this paper
• Elevated expression of mitogen-activated protein kinase phosphatase 3 in breast tumors: a mechanism of tamoxifen resistance.

  2006cited by this paper
• Effects of Ras signaling on gene expression analyzed by customized microarrays.

  2006cited by this paper
• Negative feedback predominates over cross‐regulation to control ERK MAPK activity in response to FGF signalling in embryos

  2006cited by this paper
• The effects of a novel MEK inhibitor PD184161 on MEK-ERK signaling and growth in human liver cancer.

  2006cited by this paper
• Actin' together: serum response factor, its cofactors and the link to signal transduction.

  2006cited by this paper
• Effects of sequestration on signal transduction cascades

  2006cited by this paper
• Inhibition of Gluconeogenesis through Transcriptional Activation of EGR1 and DUSP4 by AMP-activated Kinase*

  2006cited by this paper
• MAPK signal specificity: the right place at the right time.

  2006cited by this paper
• Computational modelling of the receptor-tyrosine-kinase-activated MAPK pathway.

  2005cited by this paper
• Mkp3 is a negative feedback modulator of Fgf8 signaling in the mammalian isthmic organizer.

  2005cited by this paper
• Defining the mammalian CArGome.

  2005cited by this paper
• Genome-wide analysis of cAMP-response element binding protein occupancy, phosphorylation, and target gene activation in human tissues.

  2005cited by this paper
• Control of MAPK signalling: from complexity to what really matters

  2005cited by this paper
• Graded Mitogen-Activated Protein Kinase Activity Precedes Switch-Like c-Fos Induction in Mammalian Cells

  2005cited by this paper
• Extracellular Signal-Regulated Kinases Phosphorylate Mitogen-Activated Protein Kinase Phosphatase 3/DUSP6 at Serines 159 and 197, Two Sites Critical for Its Proteasomal Degradation

  2005cited by this paper
• Inferring combinatorial regulation of transcription in silico

  2005cited by this paper
• Modeling the Nonlinear Dynamics of Cellular Signal Transduction

  2004cited by this paper
• A Spectrum of Models of Signaling Pathways

  2004cited by this paper
• Transcriptional basis of KRAS oncogene-mediated cellular transformation in ovarian epithelial cells

  2004cited by this paper
• Quantitative analysis of signaling networks.

  2004cited by this paper
• Prediction of cis-regulatory elements of coregulated genes.

  2004cited by this paper
• Applied bioinformatics for the identification of regulatory elements

  2004cited by this paper
• Decay rates of human mRNAs: correlation with functional characteristics and sequence attributes.

  2003cited by this paper
• Identification of nucleocytoplasmic cycling as a remote sensor in cellular signaling by databased modeling

  2003cited by this paper
• Transcriptional regulation by the MAP kinase signaling cascades.

  2003cited by this paper
• MKP3 mediates the cellular response to FGF8 signalling in the vertebrate limb

  2003cited by this paper
• Negative feedback regulation of FGF signaling levels by Pyst1/MKP3 in chick embryos.

  2003cited by this paper
• Trafficking of the ErbB receptors and its influence on signaling.

  2003cited by this paper
• Potential tumor suppressive pathway involving DUSP6/MKP-3 in pancreatic cancer.

  2003cited by this paper
• How robust are switches in intracellular signaling cascades?

  2003cited by this paper
• Kinetic Analysis of Platelet-derived Growth Factor Receptor/Phosphoinositide 3-Kinase/Akt Signaling in Fibroblasts*

  2003cited by this paper
• Allele-specific Holliday junction formation: a new mechanism of allelic discrimination for SNP scoring.

  2003cited by this paper
• Ras-Mediated Deregulation of Gene Expression and Contribution to Oncogenesis

  2003cited by this paper
• P API reference

  2003cited by this paper
• MAP Kinase Phosphatase As a Locus of Flexibility in a Mitogen-Activated Protein Kinase Signaling Network

  2002cited by this paper
• Genome-wide analysis of mRNA decay in resting and activated primary human T lymphocytes.

  2002cited by this paper
• Gene expression profiling in RAS oncogene-transformed cell lines and in solid tumors using subtractive suppression hybridization and cDNA arrays.

  2002cited by this paper
• A Computational Study of Feedback Effects on Signal Dynamics in a Mitogen‐Activated Protein Kinase (MAPK) Pathway Model

  2001cited by this paper
• A new mathematical model for relative quantification in real-time RT-PCR.

  2001cited by this paper
• Transcriptional regulation by the phosphorylation-dependent factor CREB

  2001cited by this paper
• Negative feedback and ultrasensitivity can bring about oscillations in the mitogen-activated protein kinase cascades.

  2000cited by this paper
• A genome-wide survey of RAS transformation targets

  2000cited by this paper
• Creation of human tumour cells with defined genetic elements

  1999cited by this paper
• Emergent properties of networks of biological signaling pathways.

  1999cited by this paper
• Why do protein kinase cascades have more than one level?

  1997cited by this paper
• Ultrasensitivity in the mitogen-activated protein kinase cascade.

  1996cited by this paper
• Control of Ha-ras-mediated mammalian cell transformation by Escherichia coli regulatory elements.

  1992cited by this paper
• Suppression and re‐expression of transformed phenotype in hybrids of HA‐ras‐1 ‐transformed rat‐1 cells and early‐passage rat embryonic fibroblasts

  1986cited by this paper
• MAP Kinase Phosphatase As a Locus of Flexibility in a Mitogen-Activated Protein Kinase Signaling Network

  year unknowncited by this paper

• Aging and Obesity Prime the Methylome and Transcriptome of Adipose Stem Cells for Disease and Dysfunction

  2022cites this paper
• Xenopus Dusp6 modulates FGF signaling precisely to pattern pre-placodal ectoderm.

  2022cites this paper
• Regulation of ERK basal and pulsatile activity control proliferation and exit from the stem cell compartment in mammalian epidermis

  2020cites this paper
• Heterogeneous pathway activation and drug response modelled in colorectal-tumor-derived 3D cultures

  2019cites this paper
• Systems Biology in Biomarker Development for Cancer Signaling Therapy

  2019cites this paper
• ZEB1 suppression sensitizes KRAS mutant cancers to MEK inhibition by an IL17RD-dependent mechanism

  2019cites this paper
• Modelling of Protein Kinase Signaling Pathways in Melanoma and Other Cancers

  2019cites this paper
• DUSP5 and DUSP6, two ERK specific phosphatases, are markers of a higher MAPK signaling activation in BRAF mutated thyroid cancers

  2017cites this paper
• Title Systems biology embedded target validation : improvingefficacy in drug discovery

  2017cites this paper
• Signalling by protein and drug development: a systems-centred view

  2017cites this paper
• THE ROLE OF THE EPITHELIAL-TO-MESENCHYMAL TRANSITION (EMT) IN LUNG CANCER PROGRESSION

  2017cites this paper
• A protein phosphatase network controls the temporal and spatial dynamics of differentiation commitment in human epidermis

  2017cites this paper
• Drug-target interaction prediction by integrating multiview network data

  2017cites this paper
• Fitting mathematical models of biochemical pathways to steady state perturbation response data without simulating perturbation experiments

  2017cites this paper
• Identification and characterisation of long non-coding RNAs expressed downstream of EGF-induced signalling programme

  2016cites this paper
• Context-specific flow through the MEK/ERK module produces cell- and ligand-specific patterns of ERK single and double phosphorylation

  2016cites this paper
• Nuclear shuttling of Y Box binding protein-1, its clinical relevance in cancer and as a therapeutic target

  2016cites this paper
• This information is current as Lipopolysaccharide Macrophage Responses to Tristetraprolin Cooperate To Regulate Dual-Specificity Phosphatase 1 and

  2015cites this paper
• DUSP4 Regulates Neuronal Differentiation and Calcium Homeostasis by Modulating ERK1/2 Phosphorylation

  2015cites this paper
• The dynamic control of signal transduction networks in cancer cells

  2015cites this paper
• Systems biology‐embedded target validation: improving efficacy in drug discovery

  2014cites this paper
• The virtual liver: state of the art and future perspectives

  2014cites this paper
• The Pseudophosphatase MK-STYX Induces Neurite-Like Outgrowths in PC12 Cells

  2014cites this paper
• Increased activity of mitogen activated protein kinase pathway in flotillin-2 knockout mouse model.

  2014cites this paper
• Insulin signaling dynamics in human adipocytes

  2014cites this paper
• Insulin signaling dynamics in human adipocytes : Mathematical modeling reveals mechanisms of insulin resistance in type 2 diabetes

  2014cites this paper
• Anomalies moléculaires de la voie MAPK et cancer papillaire de la thyroïde : étude de deux phosphatases spécifiques de ERK, DUSP5 et DUSP6

  2014cites this paper
• Mechanisms of RAS/β-catenin interactions

  2013cites this paper
• Complexity of receptor tyrosine kinase signal processing.

  2013cites this paper
• DUSP6 regulates drug sensitivity by modulating DNA damage response

  2013influential citation
• Pseudophosphatase STYX modulates cell-fate decisions and cell migration by spatiotemporal regulation of ERK1/2

  2013cites this paper
• Reverse engineering a hierarchical regulatory network downstream of oncogenic KRAS

  2012cites this paper
• Dual specificity phosphatase 6 as a predictor of invasiveness in papillary thyroid cancer.

  2012cites this paper
• Signalling by protein phosphatases and drug development: a systems‐centred view

  2012cites this paper
• Systems Biology of Fungal Infection

  2012cites this paper
• Molecular mechanisms involved in the induction of pluripotency

  2012cites this paper
• A High-throughput Assay for Phosphoprotein-specific Phosphatase Activity in Cellular Extracts*

  2012cites this paper
• Robustness of signal transduction pathways

  2012cites this paper
• Interplay of β-catenin with xenobiotic-sensing receptors and its role in glutathione S-transferase expression.

  2012cites this paper
• Knockdown of Oncogenic KRAS in Non–Small Cell Lung Cancers Suppresses Tumor Growth and Sensitizes Tumor Cells to Targeted Therapy

  2011cites this paper
• Computational Tools for Systems Biology

  2011cites this paper
• Mathematical Tools in Cancer Signalling Systems Biology

  2011influential citation
• The Hallmarks of Cancer Revisited Through Systems Biology and Network Modelling

  2011cites this paper
• Feedback regulation of EGFR signalling: decision making by early and delayed loops

  2011cites this paper
• Biology using engineering tools

  2011cites this paper
• Biochemical network-based drug-target prediction.

  2010cites this paper
• Strategies to Investigate Signal Transduction Pathways with Mathematical Modelling

  2010cites this paper
• Triple‐negative breast cancer: Present challenges and new perspectives

  2010cites this paper
• Identification of Y-Box Binding Protein 1 As a Core Regulator of MEK/ERK Pathway-Dependent Gene Signatures in Colorectal Cancer Cells

  2010cites this paper
• Biomarkers downstream of RAS: a search for robust transcriptional targets.

  2010cites this paper
• Comparative transcriptome and proteome analysis of Ha-ras and B-raf mutated mouse liver tumors.

  2009cites this paper
• RAS Mutations Impact TNF-Induced Apoptosis in Colon Carcinoma Cells via ERK-Modulatory Negative and Positive Feedback Circuits along with non-ERK Pathway Effects

  2009cites this paper
• Experiment design for systems biology

  2009cites this paper
• RAS mutations affect tumor necrosis factor-induced apoptosis in colon carcinoma cells via ERK-modulatory negative and positive feedback circuits along with non-ERK pathway effects.

  2009cites this paper
• Cancer systems biology: a network modeling perspective

  2009cites this paper
• A FIRE-y PAGE in the computational analysis of cancer profiles.

  2009cites this paper
• Explorer A protein phosphatase network controls the temporal and spatial dynamics of differentiation commitment in human epidermis

  year unknowncites this paper
• Biology using engineering tools: The negative feedback amplifier

  year unknowncites this paper
• Systems biology embedded target validation: improving efficacy in drug discovery

  year unknowncites this paper
• Systems biology embedded target validation: improving efficacy in drug discovery

  year unknowncites this paper
• Systems biology embedded target validation: improving efficacy in drug discovery

  year unknowncites this paper
• Systems biology embedded target validation: improving efficacy in drug discovery

  year unknowncites this paper
• Systems biology embedded target validation: improving efficacy in drug discovery

  year unknowncites this paper
• Systems biology embedded target validation: improving efficacy in drug discovery

  year unknowncites this paper
• Systems biology embedded target validation: improving efficacy in drug discovery

  year unknowncites this paper
• Send Orders of Reprints at Reprints@benthamscience.org Engineering Simulations for Cancer Systems Biology

  year unknowncites this paper
• Biology using engineering tools: The negative feedback amplifier

  year unknowncites this paper